Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
2 events,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Douglas DiRuggiero, PA-C
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Douglas DiRuggiero, PA-C
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Ben Ehst, MD
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Ben Ehst, MD
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
2 events,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Meagen McCusker, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Meagen McCusker, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in…
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Eingun Song, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Eingun Song, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Cory Rubin, MD
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Cory Rubin, MD
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin…
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Jason Hawkes, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Jason Hawkes, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Matt Bruno, PA-C
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Matt Bruno, PA-C
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in…
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Alexandra Golant, MD
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Alexandra Golant, MD
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
2 events,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Michael Payette, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Michael Payette, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in…
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Raj Chovatiya, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Raj Chovatiya, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Leigh Ann Pansch, NP
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Leigh Ann Pansch, NP
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Peter Lio, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Peter Lio, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Melissa Costner, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Melissa Costner, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Matthew Lewis, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Matthew Lewis, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by George Han, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by George Han, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Kristi Hawley, DO
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Kristi Hawley, DO
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Eileen Cheever, PA-C
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Eileen Cheever, PA-C
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Daniel Butler, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Daniel Butler, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
Understanding the Pathophysiology of Prurigo Nodularis (PN) and a Treatment Option for Appropriate PN Patients 18+ Years of Age
by Jonathan Silverberg, MD
Understanding the Pathophysiology of Prurigo Nodularis (PN) and a Treatment Option for Appropriate PN Patients 18+ Years of Age
by Jonathan Silverberg, MD
Learn more about the evolving understanding of the pathophysiology of prurigo nodularis (PN) and a treatment option that may help appropriate patients.
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Carsten Hamann, MD
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Carsten Hamann, MD
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age.
1 event,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Marshall Shuler, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Marshall Shuler, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Timothy Patton, DO
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Timothy Patton, DO
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Amy Spizuoco, DO
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Amy Spizuoco, DO
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
2 events,
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Jared Jagdeo, MD
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Jared Jagdeo, MD
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Adam Friedman, MD
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Adam Friedman, MD
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
1 event,
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Gina Mangin, PA-C
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Gina Mangin, PA-C
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age.
1 event,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Zakiya Rice, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Zakiya Rice, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.